Machine Learning Model Developed to Differentiate Diabetic Kidney Disease in Type 2 Diabetes
A machine learning model has been developed to differentiate diabetic kidney disease from non-diabetic kidney disease in type 2 diabetes patients.
Asset / Drug
Drug and asset intelligence for Machine with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.